Rockefeller Capital Management
INDV icon

Rockefeller Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History

Rockefeller Capital Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.4K Buy
3,096
+1,810
+141% +$59.8K ﹤0.01% 2911
2025
Q4 		$46.1K Buy
1,286
+1,076
+512% +$32.9K ﹤0.01% 3114
2025
Q3 		$5.06K Buy
+210
New +$4.39K ﹤0.01% 3871
2025
Q2 		– Sell
-50,210
Closed -$479K – 1757
2025
Q1 		$479K Buy
50,210
+210
+0.4% +$2.21K ﹤0.01% 1493
2024
Q4 		$622K Hold
50,000
– – ﹤0.01% 1410
2024
Q3 		$488K Buy
50,000
+20,000
+67% +$234K ﹤0.01% 1437
2024
Q2 		$484K Sell
30,000
-30,000
-50% -$541K ﹤0.01% 1440
2024
Q1 		$1.29M Hold
60,000
– – ﹤0.01% 1172
2023
Q4 		$916K Buy
+60,000
New +$1.07M ﹤0.01% 1171

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rockefeller Capital Management's INDV Position: Q1 2026 in Review

Rockefeller Capital Management increased its Indivior Pharmaceuticals (INDV) stake by 141% in Q1 2026, buying an estimated $59.8K and bringing the position to 3,096 shares worth $94.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2911.

Rockefeller Capital Management first reported a position in INDV in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.29M in Q1 2024. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Rockefeller Capital Management held 3,096 shares of Indivior Pharmaceuticals worth $94.4K as of Q1 2026.
  • Rockefeller Capital Management bought 1,810 Indivior Pharmaceuticals shares in Q1 2026, an estimated $59.8K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2911 holding.
  • Rockefeller Capital Management first reported a position in Indivior Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • Rockefeller Capital Management's Indivior Pharmaceuticals position peaked at $1.29M in Q1 2024.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.